9.3 C
New York
Tuesday, October 4, 2022

Buy now

spot_img

Aurobindo Pharma’s Andhra Pradesh Unit Gets Three U.S. FDA Observations



Aurobindo Pharma said that U.S. FDA has issued Form 483 with three observations after inspecting its manufacturing facility.



Source link

Related Articles

Stay Connected

0FansLike
3,513FollowersFollow
0SubscribersSubscribe
- Advertisement -spot_img

Latest Articles